Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jun 2014

Chen Qiongrong, Xia Chunjiao, Deng Yunte, Wang Mingwei, Luo Ping, Wu Changming, Yue Junqiu, Fang Na, Wang Manxiang, Wei Shaozhong

Abstract excerpt

With the increased uses of targeted therapeutics, diagnostic detection of target mutations becomes essential for the effective clinical applications of targeted therapeutics. Currently, there are two types of methods detecting target mutations in clinics: one is based on DNA sequence and the other uses the newly developed mutation-specific antibodies recognizing mutated proteins. Each method has its own...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRAF gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Melanoma

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 24563339
DOI: 10.1007/s13277-014-1759-6

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients.PMID 24563339Read ↗

Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.Semantic proximity Read ↗

Use of BRAF immunohistochemistry as a screening test in detecting BRAFV600E mutation in melanomas.Semantic proximity Read ↗

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.Semantic proximity Read ↗

The Current State of Molecular Testing in the BRAF-Mutated Melanoma LandscapeSemantic proximity Read ↗

Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma.Semantic proximity Read ↗

Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicineSemantic proximity Read ↗

Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma.Semantic proximity Read ↗

Rapid BRAF Mutation Testing in Pigmented Melanomas.Semantic proximity Read ↗

Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma.Semantic proximity Read ↗

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens.Semantic proximity Read ↗

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.Semantic proximity Read ↗

Molecular testing in melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.